Portfolio company
CSW Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
CSW Therapeutics develops a non-invasive soundwave therapy device for patients with refractory angina to regenerate heart tissue and restore cardiac function outside hospital settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CorFlow Therapeutics
This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.
SpectraWAVE
This company develops intravascular imaging systems and AI-enabled physiology tools for interventional cardiologists to treat and prevent coronary artery disease.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
EpiHeart
This company develops cardiac cell therapy devices for heart failure treatment, intended for use by surgeons during cardiac surgery.
CorFlow Therapeutics AG
This company develops medical devices for diagnosing and treating microvascular obstruction in heart attack patients for use by interventional cardiologists in catheterisation laboratories.
Avery Therapeutics
Avery Therapeutics develops tissue-engineered heart grafts to treat patients with chronic heart failure.
XyloCor Therapeutics
The company develops gene therapies to treat patients with advanced coronary artery disease and refractory angina.
CorWave
This company develops implantable heart pumps with membrane technology to provide pulsatile blood flow for patients suffering from advanced heart failure.